APH vs ITRM · P/E 40, rev $23.09B vs rev $390.0K
Amphenol Corporation (APH) versus Iterum Therapeutics PLC (ITRM) — a side-by-side from cached financials, not a winner call.
Amphenol Corporation (APH) is a electronic components company listed on US.
Iterum Therapeutics PLC (ITRM) is a biotechnology company listed on US.
Latest reported APH revenue for 2025-12-31 was $23.09B. Net income was $4.27B. Revenue was up 51.7% from 2024-12-31 to 2025-12-31. APH currently screens at market cap $170.77B and trailing P/E 39.9.
Latest reported ITRM revenue for 2025-09-30 was $390.0K. Net income was -$20.4M. ITRM currently screens at market cap $38.6M.
APH currently screens at market cap $170.77B and trailing P/E 39.9. ITRM currently screens at market cap $38.6M.
Not investment advice. Open the APH and ITRM stock pages for the full models.
Not investment advice.